Prim, S.A. (FRA:5P1)

Market Cap	216.10M +26.4%
Revenue (ttm)	240.68M +5.8%
Net Income	14.55M +27.4%
EPS	0.85 +27.1%
Shares Out	n/a
PE Ratio	14.85
Forward PE	13.15
Dividend	0.40 (3.26%)
Ex-Dividend Date	Mar 10, 2026

Volume	n/a
Average Volume	88
Open	12.15
Previous Close	12.60
Day's Range	12.15 - 12.15
52-Week Range	9.16 - 14.00
Beta	n/a
RSI	41.43
Earnings Date	Feb 27, 2026

About Prim, S.A.

Prim, S.A. operates as a health technology, mobility, and health care products provider in Spain. The company offers collar, clavicle, armsling, hand and finger, shoulder, elbow, and wrist products. Its lower limbs products include calf brace, thigh, hip, knee, ankle, and foot related products. The company provides shoulder and back supports, bands, corsets, hyperextension braces, and thoracic protectors under the airtex PRO, bruxi calm, fisionprim, newfeet, ORTHOPrim, PRIM, PRIMcare, respira PLUS, airMed, airtex, aqtivo skin, aqtivo sport, com...

• Industry: Medical, Dental, and Hospital Equipment and Supplies
• Founded: 1870
• Employees: 902
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 5P1

Financial Performance

In 2024, Prim, S.A.'s revenue was 233.36 million, an increase of 7.73% compared to the previous year's 216.62 million. Earnings were 10.92 million, a decrease of -13.83%.